| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
Departments of
*
Pathology and
Clinical Chemistry, Free University Hospital, Amsterdam, the Netherlands; and
Department of Pathophysiology of Plasma Proteins, Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands
Granzyme B is released from CTLs and NK cells and an important mediator of CTL/NK-induced apoptosis in target cells. The human intracellular serpin proteinase inhibitor (PI)9 is the only human protein able to inhibit the activity of granzyme B. As a first step to elucidate the physiological role of PI9, PI9 protein expression in various human tissues was studied. A mAb directed against human PI9 was developed, which specifically stained PI9-transfected COS-7 cells, and was used for immunohistochemistry. Both in primary lymphoid organs and in inflammatory infiltrates, PI9 was present in different subsets of dendritic cells. Also T-lymphocytes in primary and organ-associated lymphoid tissues were PI9 positive. Endothelial cells of small vessels in most organs tested as well as the endothelial layer of large veins and arteries showed strong PI9 staining. Surprisingly, high PI9 protein expression was also found at immune-privileged sites like the placenta, the testis, the ovary, and the eye. These data fit with the hypothesis that PI9 is expressed at sites where degranulation of CTL or NK cells is potentially deleterious.
This article has been cited by other articles:
|
|
 |
|
  K. A. Andrew, H. M. A. Simkins, S. Witzel, R. Perret, J. Hudson, I. F. Hermans, D. S. Ritchie, J. Yang, and F. Ronchese Dendritic Cells Treated with Lipopolysaccharide Up-Regulate Serine Protease Inhibitor 6 and Remain Sensitive to Killing by Cytotoxic T Lymphocytes In Vivo J. Immunol., December 15, 2008; 181(12): 8356 - 8362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Getachew, H. Stout-Delgado, B. C. Miller, and D. L. Thiele Granzyme C Supports Efficient CTL-Mediated Killing Late in Primary Alloimmune Responses J. Immunol., December 1, 2008; 181(11): 7810 - 7817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bots and J. P. Medema Serpins in T cell immunity J. Leukoc. Biol., November 1, 2008; 84(5): 1238 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Watchmaker, J. A. Urban, E. Berk, Y. Nakamura, R. B. Mailliard, S. C. Watkins, S. M. van Ham, and P. Kalinski Memory CD8+ T Cells Protect Dendritic Cells from CTL Killing J. Immunol., March 15, 2008; 180(6): 3857 - 3865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tapia, L. M. Gangi, F. Zegers-Hochschild, J. Balmaceda, R. Pommer, L. Trejo, I. M. Pacheco, A. M. Salvatierra, S. Henriquez, M. Quezada, et al. Differences in the endometrial transcript profile during the receptive period between women who were refractory to implantation and those who achieved pregnancy Hum. Reprod., February 1, 2008; 23(2): 340 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Stout-Delgado, Y. Getachew, B. C. Miller, and D. L. Thiele Intrahepatic Lymphocyte Expression of Dipeptidyl Peptidase I-Processed Granzyme B and Perforin Induces Hepatocyte Expression of Serine Proteinase Inhibitor 6 (Serpinb9/SPI-6) J. Immunol., November 15, 2007; 179(10): 6561 - 6567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Abdullah, T. Saric, H. Kashkar, N. Baschuk, B. Yazdanpanah, B. K. Fleischmann, J. Hescheler, M. Kronke, and O. Utermohlen Serpin-6 Expression Protects Embryonic Stem Cells from Lysis by Antigen-Specific CTL J. Immunol., March 15, 2007; 178(6): 3390 - 3399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bossard, K. Belhadj, F. Reyes, N. Martin-Garcia, F. Berger, J. A. Kummer, J. Briere, A.-C. Baglin, S. Cheze, J. Bosq, et al. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials Blood, March 1, 2007; 109(5): 2183 - 2189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S.K. de Hooge, D. Berghuis, S. J. Santos, E. Mooiman, S. Romeo, J. A. Kummer, R. M. Egeler, M. J.D. van Tol, C. J.M. Melief, P. C.W. Hogendoorn, et al. Expression of Cellular FLICE Inhibitory Protein, Caspase-8, and Protease Inhibitor-9 in Ewing Sarcoma and Implications for Susceptibility to Cytotoxic Pathways Clin. Cancer Res., January 1, 2007; 13(1): 206 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sipione, K. C. Simmen, S. J. Lord, B. Motyka, C. Ewen, I. Shostak, G. R. Rayat, J. M. Dufour, G. S. Korbutt, R. V. Rajotte, et al. Identification of a Novel Human Granzyme B Inhibitor Secreted by Cultured Sertoli Cells J. Immunol., October 15, 2006; 177(8): 5051 - 5058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Jiang, B. A. Orr, D. M. Kranz, and D. J. Shapiro Estrogen Induction of the Granzyme B Inhibitor, Proteinase Inhibitor 9, Protects Cells against Apoptosis Mediated by Cytotoxic T Lymphocytes and Natural Killer Cells Endocrinology, March 1, 2006; 147(3): 1419 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. S. van Houdt, J. J. Oudejans, A. J.M. van den Eertwegh, A. Baars, W. Vos, B. A. Bladergroen, D. Rimoldi, J. J.F. Muris, E. Hooijberg, C. M. Gundy, et al. Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma Clin. Cancer Res., September 1, 2005; 11(17): 6400 - 6407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Maltepe, G. W. Krampitz, K. M. Okazaki, K. Red-Horse, W. Mak, M. C. Simon, and S. J. Fisher Hypoxia-inducible factor-dependent histone deacetylase activity determines stem cell fate in the placenta Development, August 1, 2005; 132(15): 3393 - 3403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Hussein Apoptosis in the ovary: molecular mechanisms Hum. Reprod. Update, March 1, 2005; 11(2): 162 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Grossman, J. W. Verbsky, B. L. Tollefsen, C. Kemper, J. P. Atkinson, and T. J. Ley Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells Blood, November 1, 2004; 104(9): 2840 - 2848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Barrie, H. W. Stout, M. S. Abougergi, B. C. Miller, and D. L. Thiele Antiviral Cytokines Induce Hepatic Expression of the Granzyme B Inhibitors, Proteinase Inhibitor 9 and Serine Proteinase Inhibitor 6 J. Immunol., May 15, 2004; 172(10): 6453 - 6459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. M. Strik, A. Wolbink, D. Wouters, B. A. Bladergroen, A. R. Verlaan, I. S. van Houdt, S. Hijlkema, C. E. Hack, and J. A. Kummer Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with {beta}-tryptase monomers Blood, April 1, 2004; 103(7): 2710 - 2717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. SASSON, A. DANTES, K. TAJIMA, and A. AMSTERDAM Novel genes modulated by FSH in normal and immortalized FSH-responsive cells: new insights into the mechanism of FSH action FASEB J, July 1, 2003; 17(10): 1256 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Hirst, M. S. Buzza, C. H. Bird, H. S. Warren, P. U. Cameron, M. Zhang, P. G. Ashton-Rickardt, and P. I. Bird The Intracellular Granzyme B Inhibitor, Proteinase Inhibitor 9, Is Up-Regulated During Accessory Cell Maturation and Effector Cell Degranulation, and Its Overexpression Enhances CTL Potency J. Immunol., January 15, 2003; 170(2): 805 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Strik, B. A. Bladergroen, D. Wouters, W. Kisiel, J. H. Hooijberg, A. R. Verlaan, P. L. Hordijk, P. Schneider, C. E. Hack, and J. A. Kummer Distribution of the Human Intracellular Serpin Protease Inhibitor 8 in Human Tissues J. Histochem. Cytochem., November 1, 2002; 50(11): 1443 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kannan-Thulasiraman and D. J. Shapiro Modulators of Inflammation Use Nuclear Factor-kappa B and Activator Protein-1 Sites to Induce the Caspase-1 and Granzyme B Inhibitor, Proteinase Inhibitor 9 J. Biol. Chem., October 18, 2002; 277(43): 41230 - 41239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Vermijlen, D. Luo, C. J Froelich, J. P. Medema, J. A. Kummer, E. Willems, F. Braet, and E. Wisse Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway J. Leukoc. Biol., October 1, 2002; 72(4): 668 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Balaji, N. Schaschke, W. Machleidt, M. Catalfamo, and P. A. Henkart Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-destruction after Degranulation J. Exp. Med., August 19, 2002; 196(4): 493 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. ten Berge, C. J. L. M. Meijer, D. F. Dukers, J. A. Kummer, B. A. Bladergroen, W. Vos, C. E. Hack, G. J. Ossenkoppele, and J. J. Oudejans Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma Blood, May 29, 2002; 99(12): 4540 - 4546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Bladergroen, C. J. L. M. Meijer, R. L. ten Berge, C. E. Hack, J. J. F. Muris, D. F. Dukers, A. Chott, Y. Kazama, J. J. Oudejans, O. van Berkum, et al. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood, January 1, 2002; 99(1): 232 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Krieg, A. J. Krieg, and D. J. Shapiro A Unique Downstream Estrogen Responsive Unit Mediates Estrogen Induction of Proteinase Inhibitor-9, a Cellular Inhibitor of IL-1{beta}- Converting Enzyme (Caspase 1) Mol. Endocrinol., November 1, 2001; 15(11): 1971 - 1982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Medema, D. H. Schuurhuis, D. Rea, J. van Tongeren, J. de Jong, S. A. Bres, S. Laban, R. E.M. Toes, M. Toebes, T. N.M. Schumacher, et al. Expression of the Serpin Serine Protease Inhibitor 6 Protects Dendritic Cells from Cytotoxic T Lymphocyte-Induced Apoptosis: Differential Modulation by T Helper Type 1 and Type 2 Cells J. Exp. Med., September 3, 2001; 194(5): 657 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Medema, J. de Jong, L. T. C. Peltenburg, E. M. E. Verdegaal, A. Gorter, S. A. Bres, K. L. M. C. Franken, M. Hahne, J. P. Albar, C. J. M. Melief, et al. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors PNAS, September 25, 2001; 98(20): 11515 - 11520. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
